Cargando…
A physiologically‐based pharmacokinetic model for tuberculosis drug disposition at extrapulmonary sites
Tuberculosis (TB) is a leading cause of mortality attributed to an infectious agent. TB primarily targets the lungs, but in about 16% cases can affect other organs as well, giving rise to extrapulmonary TB (EPTB). However, an optimal regimen for EPTB treatment is not defined. Although the recommende...
Autores principales: | Ramachandran, Aparna, Gadgil, Chetan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508491/ https://www.ncbi.nlm.nih.gov/pubmed/37431175 http://dx.doi.org/10.1002/psp4.13008 |
Ejemplares similares
-
Development of Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Indomethacin Disposition in Pregnancy
por: Alqahtani, Saeed, et al.
Publicado: (2015) -
In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition
por: Murata, Yukiko, et al.
Publicado: (2022) -
Physiologically-based pharmacokinetic model for pulmonary disposition of protein therapeutics in humans
por: Jagdale, Prabhas, et al.
Publicado: (2022) -
Predicting Paclitaxel Disposition in Humans With Whole‐Body Physiologically‐Based Pharmacokinetic Modeling
por: Fu, Qiang, et al.
Publicado: (2019) -
Application of a physiologically based pharmacokinetic model to predict isoniazid disposition during pregnancy
por: Amaeze, Ogochukwu U., et al.
Publicado: (2023)